Advitech Inc, which changed its name to Botaneco Corp on October 7, 2011 has developed a whey protein fraction enriched in TGF-β2 called XP-828L. This proprietary ingredient plays a role in the prevention of immune-mediated inflammatory disorders such as psoriasis and inflammatory bowel disease. Botaneco Corp. produces Dermylex® which was shown in one open-label and two double-blind, placebo-controlled studies to help improve the symptoms of psoriasis in patients suffering from the mild-to-moderate form of psoriasis.
For more information on XP-828L or the Dermylex® technology, please visit us at our new website www.botanecocorp.com.
|
|
 |
XP-828L
XP-828L is a protein complex derived from dairy which naturally relieves mild to moderate psoriasis... Read more |
 |
Dermylex®
Dermylex® is the commercial trademark for XP-828L sold in bottles or blisters... Read more
|
For retail customers looking to purchase our Dermylex® product, please contact us for ordering information.
Dermylex ™, 60 400 mg caplets (1-month supply): $59.99 CND/unit.
A new patented oral solution, clinically proven efficient and safe for people suffering from mild to moderate psoriasis. Clinical trials show that best results are achieved after 2 months of use. Natural health product.